Kelun-Biotech's Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC

CHENGDU,China,Jan. 23,2025--Sichuan Kelun-Biotech Biopharmaceutical Co.,Ltd. (the "Company") announced that the Company received marketing authorization in China from National Medical Produc

Focus

Jan 26, 2025

Willog to Showcase Its Logistics Intelligence Solutions at Manifest 2025

LAS VEGAS,Jan. 23,2025-- Willog (www.willog.io),a leading provider of IoT-based logistics intelligence solutions,today announced its participation in Manifest 2025,a premier international logistics ev

Focus

Jan 26, 2025

E-POWER leads global market innovation with LED power supplies

SEOUL,South Korea,Jan. 23,2025-- E-POWER CO.,LTD,a company specializing in the design and production of LED power supplies,is attracting attention in the global market for its ultra-slim,high-efficien

Focus

Jan 26, 2025

Coway Issues Official Statement Responding to Align Partners' Shareholder's Proposal

Align Partners submitted its shareholder\'s proposal through Seoul-based law firm Hannuri Law LLC on January 7th,2025

Focus

Jan 26, 2025

Xinjiang Turfan: Establishing a Comprehensive Wind Power Industry Chain to Become a Leading Power Supplier

TURFAN,China,Jan. 23,2025-- On January 23,the successful grid connection of theXiaocaohu region\'s 805,000 kW wind power project brought the total installed capacity of wind power in the Turfan power

Focus

Jan 26, 2025

LightInTheBox Receives Non-compliance Letter from NYSE Regarding Market Capitalization

SINGAPORE,Jan. 24,2025-- LightInTheBox Holding Co.,Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"),a global online retailer focusing on proprietary apparel brands and design-d

Focus

Jan 26, 2025

Focus

Kelun-Biotech&#039;s Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC

Willog to Showcase Its Logistics Intelligence Solutions at Manifest 2025

E-POWER leads global market innovation with LED power supplies

Coway Issues Official Statement Responding to Align Partners&#039; Shareholder&#039;s Proposal

Xinjiang Turfan: Establishing a Comprehensive Wind Power Industry Chain to Become a Leading Power Supplier

LightInTheBox Receives Non-compliance Letter from NYSE Regarding Market Capitalization

Kelun-Biotech's Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC

Coway Issues Official Statement Responding to Align Partners' Shareholder's Proposal